Alan Chu

1.1k total citations
18 papers, 496 citations indexed

About

Alan Chu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Alan Chu has authored 18 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Alan Chu's work include Epigenetics and DNA Methylation (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Alan Chu is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Alan Chu collaborates with scholars based in China, United States and Canada. Alan Chu's co-authors include Jeremy S. Caldwell, Bin Wang, Hong Yin, Deborah G. Nguyen, Wěi Li, Francella J. Otero, David von Schack, V.A.M. Vincent, Li Gan and Shiming Ye and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Alan Chu

15 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Chu China 8 300 131 121 80 61 18 496
Pascal Merchiers Belgium 9 364 1.2× 146 1.1× 84 0.7× 259 3.2× 32 0.5× 18 638
Mirta Mihovilovic United States 17 419 1.4× 78 0.6× 53 0.4× 107 1.3× 55 0.9× 33 663
Candan A Akar United States 7 320 1.1× 111 0.8× 51 0.4× 186 2.3× 22 0.4× 8 476
Angela Jeong United States 11 203 0.7× 106 0.8× 33 0.3× 135 1.7× 42 0.7× 15 412
Sul‐Hee Chung South Korea 13 465 1.6× 80 0.6× 80 0.7× 313 3.9× 32 0.5× 18 942
Katharina Simon Germany 15 433 1.4× 206 1.6× 29 0.2× 103 1.3× 97 1.6× 21 702
Raja Bhattacharyya United States 13 423 1.4× 107 0.8× 47 0.4× 275 3.4× 81 1.3× 19 641
Natalie Landman United States 7 276 0.9× 162 1.2× 34 0.3× 146 1.8× 35 0.6× 13 501
Marcela Sjöberg Chile 13 484 1.6× 73 0.6× 36 0.3× 187 2.3× 19 0.3× 18 677
Stephan Schilling Germany 16 289 1.0× 96 0.7× 86 0.7× 333 4.2× 17 0.3× 45 668

Countries citing papers authored by Alan Chu

Since Specialization
Citations

This map shows the geographic impact of Alan Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Chu more than expected).

Fields of papers citing papers by Alan Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Chu. The network helps show where Alan Chu may publish in the future.

Co-authorship network of co-authors of Alan Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Chu. A scholar is included among the top collaborators of Alan Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Chu. Alan Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chu, Alan, et al.. (2025). Drug repurposing screen identifies an HRI activating compound that promotes adaptive mitochondrial remodeling in MFN2-deficient cells. Proceedings of the National Academy of Sciences. 122(48). e2517552122–e2517552122.
2.
Rouch, C., Arnab K. Chatterjee, Alan Chu, et al.. (2024). Synthesis and Structure-Activity Relationship of Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease with Antiviral Potency. Bioorganic & Medicinal Chemistry Letters. 116. 130034–130034.
3.
Chu, Alan, Chen Sun, Zongwen Liu, et al.. (2024). Circ‐POSTN promotes the progression and reduces radiosensitivity in esophageal cancer by regulating the miR‐876‐5p/FYN axis. Thoracic Cancer. 15(13). 1082–1094. 4 indexed citations
6.
Sun, Chen, et al.. (2024). Bioinformatics analysis and experimental verification of NLRX1 as a prognostic factor for esophageal squamous cell carcinoma. Oncology Letters. 27(6). 264–264. 1 indexed citations
7.
Wang, Xin, Zongwen Liu, Alan Chu, et al.. (2023). Hsa_circ_0052611 and mir-767-5p guide the warburg effect, migration, and invasion of BRCA cells through modulating SCAI. Journal of Bioenergetics and Biomembranes. 55(5). 381–396. 5 indexed citations
8.
Song, Rui, et al.. (2023). Knockdown of circMFN2 inhibits cell progression and glycolysis by miR‐198/CUL4B pathway in ovarian cancer. Journal of Biochemical and Molecular Toxicology. 37(8). e23383–e23383. 7 indexed citations
9.
Sun, Chen, Alan Chu, Rui Song, et al.. (2023). PARP inhibitors combined with radiotherapy: are we ready?. Frontiers in Pharmacology. 14. 1234973–1234973. 17 indexed citations
10.
Nair, Reji, Alan Chu, Ian A. Wilson, et al.. (2022). Amyloidogenic immunoglobulin light chain kinetic stabilizers comprising a simple urea linker module reveal a novel binding sub-site. Bioorganic & Medicinal Chemistry Letters. 60. 128571–128571. 7 indexed citations
11.
Santos‐Martins, Diogo, Reji Nair, Alan Chu, et al.. (2021). Discovery of Potent Coumarin-Based Kinetic Stabilizers of Amyloidogenic Immunoglobulin Light Chains Using Structure-Based Design. Journal of Medicinal Chemistry. 64(9). 6273–6299. 25 indexed citations
12.
Chu, Alan, Rui Song, Cheng Wang, et al.. (2020). Experimental Study and Clinical Observation on the Improvement Effect of Lienal Polypeptide on Blood Toxicity and Immune Injury Induced by Radiotherapy. Genetic Testing and Molecular Biomarkers. 24(2). 73–77.
13.
Chu, Alan, et al.. (2017). High incidence of coding gene mutations in mitochondrial DNA in esophageal cancer. Molecular Medicine Reports. 16(6). 8537–8541. 8 indexed citations
14.
Zhang, Yan, Alan Chu, Bing Liang, et al.. (2017). Identification of abnormal nuclear and mitochondrial genes in esophageal cancer cells. Molecular Medicine Reports. 17(2). 2817–2826. 2 indexed citations
15.
Chu, Alan, et al.. (2009). Identification and Characterization of a Small Molecule Antagonist of Human VPAC2 Receptor. Molecular Pharmacology. 77(1). 95–101. 25 indexed citations
16.
Yin, Hong, Alan Chu, Wěi Li, et al.. (2009). Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ Assay. Journal of Biological Chemistry. 284(18). 12328–12338. 256 indexed citations
17.
Gan, Li, Shiming Ye, Alan Chu, et al.. (2004). Identification of Cathepsin B as a Mediator of Neuronal Death Induced by Aβ-activated Microglial Cells Using a Functional Genomics Approach. Journal of Biological Chemistry. 279(7). 5565–5572. 115 indexed citations
18.
Chu, Alan, et al.. (1979). The rep mutation. VI. Purification and properties of the Escherichia coli rep protein, DNA helicase III. Canadian Journal of Biochemistry. 57(6). 855–866. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026